United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Healthcare Industry News Roche secures FDA approval for HER2-ultralow metastatic breast cancer diagnostic Roche has received FDA approval for an expanded use of its PATHWAY HER2 (4B5) test, marking a significant… byPallavi MadhirajuFebruary 2, 2025